http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2397731-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13fd2ca50fabbda9f80d7ba79bc44f9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3e787a6871df4284213bb52de1883d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43518 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate | 2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d425f2dedd4fc08448dc653a464f941a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f08d15a947cce1560487b36aa7fd0962 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92ee2aaa84c65f05336e202444681b95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_163de3a0db0de5f1d59853ea9316cb3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8cd44f421e4d04831825d0b23aa07cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59fac16f9bf8dfe0e454de9b84e2115a |
| publicationDate | 2001-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2397731-A1 |
| titleOfInvention | Immunogen antivenom and vaccine against the venom of the black widow sp ider |
| abstract | The invention relates to a recombinant polypeptide that comprises the N-terminal region of .alpha.-Latrotoxin, is capable of generating an immune response in mammals and efficiently and fully neutralizes the venom of the black widow spider. The invention also relates to the cDNA coding for said polypeptide, the vector for the expression thereof, the bacterial cells transformed into said vector and the method for producing the polypeptide by means of cultivation of said cells. The invention further relates to the use of said recombinant polypeptide as a vaccine against the poison of the black widow spider and to the pharmaceutically acceptable preparations of said vaccine. The invention additionally relates to the use of said recombinant polypeptide as immunogen for generating antivenom serum for the black widow spider, obtaining serotherapeutic agents by serum purification and fab therapeutic agents by enzymatic hydrolysis of the antibodies of the serum. The invention also relates to an immunogen matrix that is useful in the separation and purification of antibodies and the specific fragments thereof against the venom of the black widow spider. |
| priorityDate | 1999-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 411.